Leg ulcers are a common health problem. Ulcers of any etiology including venous ulcers may be very painful, but until recently, health professionals have not been good at recognizing or managing this type of pain. It is important to clarify the type, severity, and frequency of pain and to anticipate pain at dressing changes. The measurement of pain by the use of pain scales is very useful, particularly in assessing the efficacy of an intervention. Neuropathic pain and unusually painful ulcerations are discussed in this article.
Get full access to this article
View all access options for this article.
References
1.
1. O’Brien JF, Grace PA, Perry IJ, et al. Prevalence and aetiology of leg ulcers in Ireland. Ir J Med Sci2000;169: 110-112.
2.
2. Callam MJ, Ruckley CV, Harper DR, et al. Chronic ulceration of the leg: extent of the problem and provision of care. Br Med J (Clin Res Ed)1985;290: 1855-1856.
3.
3. Hofman D, Ryan TJ, Arnold F, et al. Pain in venous leg ulcers. J Wound Care1997;6: 222-224.
4.
4. Noonan L, Burge SM. Venous leg ulcers: is pain a problem? Phlebology1998;13: 14-19.
5.
5. Lindholm C, Bjellerup M, Christensen OB, et al. Quality of life in chronic leg ulcer patients. An assessment according to the Nottingham Health Profile. Acta Derm Venereol1993;73: 440-443.
6.
6. Hyland ME, Ley A. Quality of life of leg ulcer patients: questionnaire and preliminary findings. J Wound Care1994;3: 294-298.
7.
7. Nelzen O, Bergqvist D, Lindhagen A. Venous and non-venous leg ulcers: clinical history and appearance in a population study. Br J Surg1994;81: 182-187.
8.
8. Phillips T, Stanton B, Provan A, et al. A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications. J Am Acad Dermatol1994;31: 49-53.
9.
9. Franks PJ, Moffatt CJ. Who suffers most from leg ulceration? J Wound Care1998;7: 383-385.
10.
10. Walshe C. Living with a venous leg ulcer: a descriptive study of patients’ experiences. J Adv Nurs1995;22: 1092-1100.
11.
11. Hollinworth H. Nurses’ assessment and management of pain at wound dressing changes. J Wound Care1995;4: 77-83.
12.
12. Moffatt C, Franks PJ, Hollingworth H. Understanding wound pain and trauma: an international perspective. European Wound Management Association Position Paper; 2002. p. 2-7.
13.
13. Spruce MC, Potter J, Coppini DV. The pathogenesis and management of painful diabetic neuropathy: a review. Diabet Med2003;20: 88-98.
14.
14. Wulf H, Baron R. The theory of pain. European Wound Management Association Position Paper; 2002. p. 8-11.
15.
15. McQuay HJ, Dickenson AH. Implications of nervous system plasticity for pain management. Anaesthesia1990;45: 101-102.
16.
16. McQuay H, Moore A. Pain measurement, study design, and validity. In: McQuay H, Moore A, editors. An evidence-based resource for pain relief. Oxford (UK): Oxford University Press; 1998, p. 14-18.
17.
17. Huskisson EC. Visual analogue scales. In: Melzack R, editor. Pain measurement and assessment. Vol. 1. New York: Raven; 1983. p. 33-37.
18.
18. Chapman CR, Casey KL, Dubner R, et al. Pain measurement: an overview. Pain1985;22: 1-31.
19.
19. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain1975;1: 277-299.
20.
20. Melzack R. The short-form McGill Pain Questionnaire. Pain1987;30: 191-197.
21.
21. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol1994;19: 210-216.
22.
22. Franks PJ, McCullagh L, Moffatt CJ. Assessing quality of life in patients with chronic leg ulceration using the Medical Outcomes Short Form-36 questionnaire. Ostomy Wound Manage2003;49: 26-37.
23.
23. Charles H. Venous leg ulcer pain and its characteristics. J Tissue Viability2002;12: 154-158.
24.
24. Oien RF, Hakansson A, Hansen BU. Leg ulcers in patients with rheumatoid arthritis—a prospective study of aetiology, wound healing and pain reduction after pinch grafting. Rheumatology (Oxford)2001;40: 816-820.
25.
25. Walters SJ, Morrell CJ, Dixon S. Measuring health-related quality of life in patients with venous leg ulcers. Qual Life Res1999;8: 327-336.
26.
26. Franks PJ, Moffatt CJ, Connolly M, et al. Community leg ulcer clinics: effect on quality of life. Phlebology1994;9: 83-86.
27.
27. Dunn JM, Cosford EJ, Kernick VF, et al. Surgical treatment for venous ulcers: is it worthwhile? Ann R Coll Surg Engl1995;77: 421-424.
28.
28. Jull AB, Waters J, Arroll B. Oral pentoxifylline for treatment of venous leg ulcers. Cochrane Database Syst Rev2000; CD001733.
29.
29. Kaur C, Sarkar R, Kanwar AJ, et al. An open trial of calcium dobesilate in patients with venous ulcers and stasis dermatitis. Int J Dermatol2003;42: 147-152.
30.
30. Diehm C, Trampisch HJ, Lange S, et al. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet1996;347: 292-294.
31.
31. Veves A, Manes C, Murray HJ, et al. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care1993;16: 1187-1189.
32.
32. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract2000;47: 123-128.
33.
33. Masson EA, Hunt L, Gem JM, et al. A novel approach to the diagnosis and assessment of symptomatic diabetic neuropathy. Pain1989;38: 25-28.
34.
34. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial. Arch Ophthalmol1995;113: 36-51.
35.
35. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med1993;329: 977-986.
36.
36. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet1998;352: 837-853.
37.
37. Ziegler D, Mayer P, Wiefels K, et al. Assessment of small and large fiber function in long-term type 1 (insulin-dependent) diabetic patients with and without painful neuropathy. Pain1988;34: 1-10.
39. Greene DA, Lattimer SA, Sima AA. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med1987;316: 599-606.
40.
40. Boulton AJ. Current and emerging treatment for the diabetic neuropathies. Diabetes Rev1999;7: 379-386.
41.
41. Callam MJ, Ruckley CV, Dale JJ, et al. Hazards of compression treatment of the leg: an estimate from Scottish surgeons. Br Med J (Clin Res Ed)1987;295: 1382.
42.
42. Hafner J. Management of arterial leg ulcers and of combined (mixed) venous-arterial leg ulcers. Curr Probl Dermatol1999;27: 211-219.
43.
43. Phillips TJ. Successful methods of treating leg ulcers. The tried and true, plus the novel and new. Postgrad Med1999;105: 159-161, 65-66, 73-74, passim.
44.
44. Beard JD. ABC of arterial and venous disease: chronic lower limb ischaemia. BMJ2000;320: 854-857.
45.
45. Mashiah A, Soroker D, Pasik S, et al. Phenol lumbar sympathetic block in diabetic lower limb ischemia. J Cardiovasc Risk1995;2: 467-469.
46.
46. Johnson WC, Watkins MT, Baldwin D, et al. Foot TcPO2 response to lumbar sympathectomy in patients with focal ischemic necrosis. Ann Vasc Surg1998;12: 70-74.
47.
47. AbuRahma AF, Robinson PA. Clinical parameters for predicting response to lumbar sympathectomy in patients with severe lower limb ischemia. J Cardiovasc Surg (Torino)1990;31: 101-106.
48.
48. Mailis A, Furlan A. Sympathectomy for neuropathic pain. Cochrane Database Syst Rev2003; CD002918.
49.
49. Loosemore TM, Chalmers TC, Dormandy JA. A meta-analysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease. Int Angiol1994;13: 133-142.
50.
50. Thompson PD, Zimet R, Forbes WP, et al. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol2002;90: 1314-1319.
51.
51. Girolami B, Bernardi E, Prins MH, et al. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med1999;159: 337-345.
52.
52. Radack K, Wyderski RJ. Conservative management of intermittent claudication. Ann Intern Med1990;113: 135-146.
53.
53. Acland KM, Darvay A, Wakelin SH, et al. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol1999;140: 131-135.
54.
54. Boyvat A, Kundakci N, Babikir MO, et al. Livedoid vasculopathy associated with heterozygous protein C deficiency. Br J Dermatol2000;143: 840-842.
55.
55. Biedermann T, Flaig MJ, Sander CA. Livedoid vasculopathy in a patient with factor V mutation (Leiden). J Cutan Pathol2000;27: 410-412.
56.
56. Calamia KT, Balabanova M, Perniciaro C, et al. Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation. J Am Acad Dermatol2002;46: 133-137.
57.
57. Lee JH, Choi HJ, Kim SM, et al. Livedoid vasculitis responding to PUVA therapy. Int J Dermatol2001;40: 153-157.
58.
58. Graves JW, Morris JC, Sheps SG. Martorell’s hypertensive leg ulcer: case report and concise review of the literature. J Hum Hypertens2001;15: 279-283.
59.
59. Henderson CA, Highet AS, Lane SA, et al. Arterial hypertension causing leg ulcers. Clin Exp Dermatol1995;20: 107-114.
60.
60. Duncan HJ, Faris IB. Martorell’s hypertensive ischemic leg ulcers are secondary to an increase in the local vascular resistance. J Vasc Surg1985;2: 581-584.
61.
61. Smith NK, Pasero CL, McCaffery M. Nondrug measures for painful procedures. Am J Nurs1997;97: 18-20.
62.
62. Briggs M, Nelson EA. Topical agents or dressings for pain in venous leg ulcers. Cochrane Database Syst Rev2003; CD001177.
63.
63. Oien RF, Hansen BU, Hakansson A. Pinch graft skin transplantation for leg ulcers in primary care. J Wound Care2000;9: 217-220.
64.
64. Jones JE, Nelson EA. Skin grafting for venous leg ulcers. Cochrane Database Syst Rev2000; CD001737.
